Search

26 Jul 2024: demonstrate the capabilities and economics of the process to investors and waste handlers and is currently undergoing household waste recycling trials./p div class="blockquote-wrap" blockquote div class="quote" pWe ... By demonstrating the societal and

26 Jul 2024: pre pPredictImmune is developing prognostic tests for immune-mediated conditions to aid in their management and improve patient outcomes. ... and the MRC Rosalind Franklin Centre for Genomics Research./p pPredictImmune has carried out considerable market

26 Jul 2024: The funds will be used to test the novel p300/CBP inhibitor in late stage, treatment-resistant prostate cancer (up to Phase IIb). ... of Seed Funds at Cambridge Enterprise, said “We are very pleased to see the significant economic and societal impact

26 Jul 2024: launch of a href="https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-invests-in-predictimmune/" target="_blank" rel="noopener noreferrer"Predictimmune/a, which is developing tests to determine whether patients ... billion. That cumulative

26 Jul 2024: the biosciences and it is vital that we capitalise on this strength to deliver the maximum social and economic benefit. ... of Seed Funds at Cambridge Enterprise, said “We are very pleased to see the significant economic and societal impact that our

26 Jul 2024: pre pPredictImmune is developing prognostic tests for immune-mediated conditions to aid in their management and improve patient outcomes. ... and the MRC Rosalind Franklin Centre for Genomics Research./p pPredictImmune has carried out considerable market

26 Jul 2024: 000 specialist lung function tests are carried out annually, and yet one in three patients is unable to use a spirometer, the existing technology used to monitor lung function. ... an innovation-led economic recovery, through collaborative research,

26 Jul 2024: addressingan audience of 200 at Ideas to Reality 2018, held Wednesday in the Great Hall of King’s College./p p“The future economic growth and well being of this country ... noopener noreferrer"PredictImmune/a—addressing an unmet need for prognostic

26 Jul 2024: The objective is to build a portfolio of new products to complement and enrich PredictImmune’s prognostic test pipeline in the coming years./p pThe level of financing reflects the success ... This will significantly improve clinical outcomes and

26 Jul 2024: pre pPredictImmune is developing prognostic tests for immune-mediated conditions to aid in their management and improve patient outcomes. ... and the MRC Rosalind Franklin Centre for Genomics Research./p pPredictImmune has carried out considerable market